Meihua Grp. Int'l Trading (Hong Kong) Ltd. v. United States

686 F. Supp. 3d 1359, 2024 CIT 21
United States Court of International Trade·Decided February 22, 2024·No. Consol. 22-00069·Published·Cited by 1 cases

Opinion

Slip Op. 24-21

UNITED STATES COURT OF INTERNATIONAL TRADE

MEIHUA GROUP INTERNATIONAL TRADING (HONG KONG), LIMITED and XINJIANG MEIHUA AMINO ACID CO., LTD., Plaintiffs,

and Before: Jennifer Choe-Groves, Judge DEOSEN BIOCHEMICAL (ORDOS), LTD., DEOSEN Consol. Court No. 22-00069 BIOCHEMICAL, LTD., and JIANLONG BIOTECHNOLOGY COMPANY, LTD., Consolidated Plaintiffs,

v. UNITED STATES, Defendant.

OPINION AND ORDER

[Remanding the U.S. Department of Commerce’s Final Results of Redetermination Pursuant to Court Order in the antidumping duty administrative review of xanthan gum from the People’s Republic of China].

Dated: February 22, 2024

Mark B. Lehnardt, Law Offices of David L. Simon, PLLC, of Washington, D.C., for Plaintiffs Meihua Group International Trading (Hong Kong), Limited and Xinjiang Meihua Amino Acid Co., Ltd.

Chunlian (Lian) Yang and Lucas Queiroz Pires, Alston & Bird, LLP, of Washington, D.C., for Consolidated Plaintiffs Deosen Biochemical (Ordos), Ltd. and Deosen Biochemical, Ltd.

Robert G. Gosselink, Jonathan M. Freed, and Kenneth N. Hammer, Trade Pacific, PLLC, of Washington, D.C., for Consolidated Plaintiff Jianlong Biotechnology Company, Ltd.

Sosun Bae, Senior Trial Attorney, Commercial Litigation Branch, Civil Division, U.S. Department of Justice, of Washington, D.C., for Defendant United States. With her on the brief were Brian M. Boynton, Principal Deputy Assistant Attorney General, Patricia M. McCarthy, Director, and Tara K. Hogan, Assistant Director. Of Counsel was Spencer Neff, Attorney, Office of the Chief Counsel for Trade Enforcement and Compliance, U.S. Department of Commerce.

Choe-Groves, Judge: Before the Court is the U.S. Department of Commerce’s (“Commerce”) remand redetermination in the administrative review of the antidumping duty order on xanthan gum from the People’s Republic of China (“China”) covering the period of review from July 1, 2019 through June 30, 2020. See Final Results of Redetermination Pursuant to Court Remand (“Remand Redetermination”), ECF Nos. 52-1, 53-1, pursuant to the Court’s Opinion and Order in Meihua Group International Trading (Hong Kong), Ltd. v. United States (“Meihua I”), 47 CIT __, 633 F. Supp. 3d 1203 (2023); see also Xanthan Gum from the People’s Republic of China (“Final Results”), 87 Fed. Reg. 7104 (Dep’t of Commerce Feb. 8, 2022) (final results of antidumping duty administrative review and final determination of no shipments; 2019–2020); see also Issues and Decision Memorandum for the Final Results of the 2019‒2020 Antidumping Duty

Administrative Review of Xanthan Gum from the People’s Republic of China (“IDM”), ECF No. 23-3.

The Court reviews Commerce’s determination to apply total adverse facts available to Meihua Group International Trading (Hong Kong), Limited and Xinjiang Meihua Amino Acid Co., Ltd. (collectively, “Meihua”). In summary, Commerce requested that Meihua provide information about what duties it paid, and Meihua reported the duties paid to the U.S. Department of Customs and Border Protection (“Customs”). IDM at 9, 12. It became apparent later that Meihua’s duties paid to Customs are subject to change due to ongoing Section 301 exclusion requests, and the duties already paid might be potentially adjusted in the future. Id. at 10, 12‒13. Meihua provided updated information requested by Commerce, but Commerce continues to fault Meihua and apply total adverse facts available for failing to provide accurate information about its U.S. duties and sales database.

In Meihua I, the Court remanded for Commerce to reconsider the application of total adverse facts available and the highest dumping margin rate to Meihua because the Court concluded that Commerce failed to satisfy its statutory obligation under 19 U.S.C. § 1677m(d). Meihua I, 47 CIT at __, 633 F. Supp. 3d at 1212. The Court directed Commerce to reconsider the applicable separate rate for Consolidated Plaintiffs Jianlong Biotechnology Co., Ltd. (“Jianlong”) and Deosen Biochemical

(Ordos), Ltd. and Deosen Biochemical, Ltd. (collectively, “Deosen”) if Commerce made any changes to Meihua’s rate. Id. at __, 633 F. Supp. 3d at 1213. The Court also directed Commerce to perform a collapsing analysis pursuant to 19 C.F.R. § 351.401(f) to determine whether Deosen Biochemical, Ltd. was an exporter with shipments of subject merchandise during the period of review, whether the Deosen entities should have been collapsed, and whether Commerce should have rescinded Deosen Biochemical, Ltd.’s review. Id. at __, 633 F. Supp. 3d at 1215.

Meihua filed Comments of Meihua Group International Trading (Hong Kong), Limited and Xinjiang Meihua Acid Co., Ltd., on Remand Redetermination. Meihua’s Cmts. Remand Redetermination (“Meihua’s Cmts.”), ECF Nos. 57, 58. Jianlong filed Comments on Final Results of Redetermination Pursuant to Court Remand of Consolidated Plaintiff Jianlong Biotechnology Co., Ltd. Jianlong’s Cmts. Final Results Redetermination Pursuant Court Remand (“Jianlong’s Cmts.”), ECF No. 55. Deosen filed Consolidated Plaintiff Deosen’s Comments in Opposition to the Final Results of Redetermination Pursuant to Court Remand. Deosen’s Cmts. Opp’n Final Results Redetermination Pursuant Court Remand (“Deosen’s Cmts.”), ECF No. 56. Defendant United States (“Defendant” or “the Government”) filed Defendant’s Response to Plaintiffs’ and Plaintiff-Intervenors’ Comments Regarding the Remand Redetermination. Def.’s Resp. Pls.’ Pl.- Intervs.’ Cmts. Regarding Remand Redetermination (“Def.’s Resp.”), ECF Nos.

59, 60. For the reasons discussed below, the Court remands Commerce’s Remand Redetermination.

ISSUES PRESENTED

The Court reviews the following issues:

1. Whether Commerce’s determination to apply total adverse facts available to Meihua is supported by substantial evidence and in accordance with law;

2. Whether Commerce’s determination to apply the separate rate to Jianlong and Deosen is supported by substantial evidence; and 3. Whether Commerce’s determination not to conduct a collapsing analysis of Deosen and rescind Deosen Biochemical, Ltd.’s review is supported by substantial evidence.

BACKGROUND

The Court presumes familiarity with the underlying facts and procedural history of this case as set forth in Meihua I, 47 CIT at __, 633 F. Supp. 3d at 1207‒ 08.

On September 3, 2020, Commerce initiated an administrative review of an antidumping duty order on xanthan gum from China. Initiation of Antidumping and Countervailing Duty Administrative Reviews (“Initiation Notice”), 85 Fed. Reg. 54,983 (Dep’t of Commerce Sept. 3, 2020). Commerce selected Meihua as

one of the mandatory respondents. Commerce’s Mem. Re: Selection Resps. 2019‒ 2020 Admin. Rev. Antidumping Duty Order Xanthan Gum People’s Rep. China at 1, PR 39.1 During the investigation, Commerce treated Deosen Biochemical (Ordos), Ltd. and Deosen Biochemical, Ltd. as a single entity and continued to do so during the administrative review. Id. at 2 n.5 In its Final Results, Commerce applied total adverse facts available to Meihua after concluding that Meihua should have communicated to Commerce that the duties it paid and the entered values on its Customs entry forms were incorrect. IDM at 12. Commerce applied a dumping margin rate of 154.07% to Meihua. Final Results, 87 Fed. Reg. at 7105. With respect to Deosen, Commerce rejected Deosen Biochemical, Ltd.’s offer to provide additional documents and did not rescind the review of Deosen Biochemical, Ltd. IDM at 7‒8; See Deosen’s Case Br. (“Deosen’s Admin. Case Br.”) at 10, PR 293. Deosen and Jianlong (collectively, “Separate Rate Respondents”) were assigned a dumping margin rate of 77.04% for separate companies not individually investigated. Final Results, 87 Fed. Reg. at 7105. Commerce calculated the separate rate using the simple average of Meihua’s adverse facts available rate of 154.07% and the 0% rate assigned to Neimenggu Fufeng Biotechnologies Co., Ltd., Xinjiang Fufeng

Free access — add to your briefcase to read the full text and ask questions with AI

Meihua Grp. Int'l Trading (Hong Kong) Ltd. v. United States, 686 F. Supp. 3d 1359, 2024 CIT 21 (cit 2024).

686 F. Supp. 3d 1359 (Meihua Grp. Int'l Trading (Hong Kong) Ltd. v. United States) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Meihua Grp. Int'l Trading (Hong Kong) Ltd. v. United States
717 F. Supp. 3d 1341 (Court of International Trade, 2024)